|
SARS-CoV-2 Nucleoprotein, 325-339
|
|
|
|
SARS-CoV-2 Nucleoprotein, 40-54
|
|
|
|
SARS-CoV-2 Nucleoprotein, 265-274
|
|
|
|
SARS-CoV-2 Nucleoprotein, 329-346
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 958-966
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 424-433
|
|
|
|
SH-Pentapeptide-1
|
sh-五肽-1
|
|
|
Oligopeptide-6
|
寡肽-6
|
|
|
Tetrapeptide-1
|
四肽-1
|
1632354-04-1
|
|
Acetyl Tetrapeptide-15
|
乙酰基四肽-15
|
928007-64-1
|
|
Acetyl Dipeptide-3 Aminohexanoate
|
乙酰基二肽-3氨基己酸乙酯
|
1176133-78-0
|
|
Palmitoyl Tripeptide-8
|
棕榈酰三肽-8
|
936544-53-5
|
|
Acetyl Tetrapeptide-2
|
乙酰基四肽-2
|
757942-88-4
|
|
Acetyl Tetrapeptide-11
|
乙酰基四肽-11
|
928006-88-6
|
|
Decapeptide-12
|
十肽-12
|
137665-91-9
|
|
Tripeptide-3
|
三肽-3
|
|
|
Oligopeptide-10
|
寡肽-10
|
466691-40-7
|
|
Tetrapeptide-4
|
四肽-4
|
|
|
Acetyl Tetrapeptide-40
|
乙酰基四肽-40
|
1472633-28-5
|
|
Hexapepitde-3
|
六肽-3
|
|
|
Hexapeptide-10
|
六肽-10
|
146439-94-3
|
|
Oligopeptide-3
|
寡肽-3
|
|
|
Trifluoroacetyl Tripeptide-2
|
三氟乙酰基三肽-2
|
64577-63-5
|
|
Hexapeptide-11
|
六肽-11
|
100684-36-4
|
|
Copper Tripeptide-3
|
铜三肽-3
|
|
|
Acetyl Hydroxyproline
|
乙酰基羟脯氨酸
|
33996-33-7
|
|
Acetyl SH-Pentapeptide-1
|
乙酰基五肽-1
|
97530-32-0
|
|
Acetyl Hexapeptide-49
|
乙酰基六肽-49
|
1459205-54-9
|
|
Palmitoyl Dipeptide-5 Diaminohydroxybutyrate
|
棕榈酰二肽-5 二氨基羟基丁酸酯
|
794590-34-4
|
|
Dipeptide-6
|
二肽-6
|
18684-24-7
|
|
Palmitoyl Dipeptide-5 Diaminobutyroyl Hydroxythreonine
|
棕榈酰基二肽-5 二氨基丁酰羟基苏氨酸
|
883558-32-5
|
|
Myristoyl Hexapeptide-4
|
肉豆蔻酰六肽-4
|
959610-44-7
|
|
Tripeptide-10 Citrulline
|
三肽-10 瓜氨酸
|
960531-53-7
|
|
Acetyl Tripeptide-30 Citrulline
|
乙酰基三肽-30 瓜氨酸
|
2098345-00-5
|
|
Dipeptide-1
|
二肽-1/京都啡肽/Kyotorphin
|
70904-56-2
|
|
Palmitoyl Tripeptide-3
|
棕榈酰三肽-3
|
1447824-23-8
|
|
Acetyl Hexapeptide-38
|
乙酰六肽-38
|
1400634-44-7
|
|
Palmitoyl Tetrapeptide-7
|
棕榈酰四肽-7/3
|
221227-05-0
|
|
Myristoyl Pentapeptide-4
|
肉豆蔻酰五肽-4/3
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520
|
|
|
|
Angiotensin I Converting Enzyme 2, (ACE - 2) Substrate
|
Mca-Ala-Pro-Lys(Dnp)-OH
|
305336-82-7
|
|
SARS-CoV-2 Spike glycoprotein, 747-763
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335
|
|
|
|
Acetyl Dipeptide-1 Cetyl Ester
|
乙酰二肽-1 鲸蜡酯/乙酰二肽十六烷醇酯
|
196604-48-5
|
|
Palmitoyl Pentapeptide-4
|
棕榈酰五肽-4/3
|
214047-00-4
|
|
Acetyl Tetrapeptide-9
|
乙酰基四肽-9
|
928006-50-2
|
|
Hexapeptide-9
|
六肽-9
|
1228371-11-6
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx)
|
|
|
|
(Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif)
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 647-664
|
|
|
|
DX 600, ACE2 Inhibitor
|
DX 600, ACE2 Inhibitor
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541
|
|
|
|
SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx)
|
|
|
|
SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 691-699
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 996-1004
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 976-984
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 957-973
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 902-917
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 891-906
|
|
|
|
SARS-CoV-2 Nucleoprotein, 260-274
|
|
|
|
SARS-CoV-2 Nucleoprotein, 316-324
|
|
|
|
SARS-CoV-2 Nucleoprotein, 322-331
|
|
|
|
SARS-CoV-2 Nucleoprotein, 313-330
|
|
|
|
SARS-CoV-2 Nucleoprotein, 305-319
|
|
|
|
SARS-CoV-2 Nucleoprotein, 305-322
|
|
|
|
SARS-CoV-2 Membrane protein, 61-70
|
|
|
|
SARS-CoV-2 Nucleoprotein, 329-353
|
|
|
|
SARS-CoV-2 Nucleoprotein, 215-229
|
|
|
|
SARS-CoV-2 Nucleoprotein, 125-139
|
|
|
|
SARS-CoV-2 Nucleoprotein, 226-234
|
|
|
|
SARS-CoV-2 Nucleoprotein, 360-375
|
|
|
|
SARS-CoV-2 Nucleoprotein, 352-369
|
|
|
|
SARS-CoV-2 Nucleoprotein, 351-358
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 1192-1200
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 1185-1193
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 1060-1068
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 1011-1028
|
|
|
|
SARS-CoV-2 Nucleoprotein, 320-334
|
|
|
|
ARGININE/LYSINE POLYPEPTIDE
|
精氨酸/赖氨酸多肽
|
74-79-3/56-87-1
|
|
SARS-CoV-2 Nucleoprotein, 351-359
|
|
|
|
SARS-CoV-2 Spike glycoprotein, 1220-1228
|
|
|
|
SARS-CoV-2 Membrane protein, 89-97
|
|
|